Effect of herbal extracts on fatty liver disease
Phase 2
- Conditions
- fatty liver disease.Fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT2017082935963N1
- Lead Sponsor
- Vice Chancellor for research of Sabzevar University of Medicine Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 82
Inclusion Criteria
AST, ALT more than 1.5 equivalents of normal range plus sonographic confirmation; from 20 to 60 years old
Exclusion criteria :
alcoholic drinks user( now or in past); being athlete; hospitalized; Acute or chronic disease before or at the time of intervention that can affects liver function tests; Taking drugs before or at the time of intervention that could affects liver function tests; Pregnancy or breastfeeding; Younger than 20 or older than 60 years old
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Aminotransferases. Timepoint: 1-3 days before intervention and 40 days after intervention. Method of measurement: U/L.
- Secondary Outcome Measures
Name Time Method Cholestrol. Timepoint: 1-3 days before intervention and 40 days after the intervention. Method of measurement: Mg/dl.;Triglyceride. Timepoint: 1-3 days before intervention and 40 days after the intervention. Method of measurement: Mg/dl.;Fasting blood sugar. Timepoint: 1-3 days before intervention and 40 days after the intervention. Method of measurement: Mg/dl.